Cheng et al. reported that downregulation of UCA1 impaired chemoresistance of non-small cell lung cancer cells with non-T790M to gefitinib by inhibition of the AKT/mTOR pathway [11]. Here, UCA1 is linked to non-small cell lung carcinoma.